Welcome to visit Zhongnan Medical Journal Press Series journal website!

Home Articles Vol 32,2023 No.4 Detail

Comprehensive quality evaluation of Qirong Runchang oral liquid based on HPLC-QAMS quantitative control of multi-components and chemometrics analysis

Published on Apr. 27, 2023Total Views: 673 times Total Downloads: 213 times Download Mobile

Author: Xiao-Chuan FENG 1 Yan-Zhao XU 2 Jing ZHANG 1 Rui ZHANG 1

Affiliation: 1. Department of Chinese Pharmacy, Beijing Jishuitan Hospital, Beijing 100035, China 2. National Institutes for Food and Drug Control, Beijing 100050, China

Keywords: HPLC-QAMS Qirong Runchang oral liquid Relative correction factor Comprehensive quality evaluation Chemometrics Multi-components Quantitative control

DOI: 10.19960/j.issn.1005-0698.202304006

Reference: Xiao-Chuan FENG, Yan-Zhao XU, Jing ZHANG, Rui ZHANG, Comprehensive quality evaluation of Qirong Runchang oral liquid based on HPLC-QAMS quantitative control of multi-components and chemometrics analysis,2023, 32(4): 404-416.DOI: 10.19960/j.issn.1005-0698.202304006.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To establish a comprehensive quality evaluation method of Qirong Runchang oral liquid based on HPLC-QAMS quantitative control of multi-components and chemometrics analysis.

Methods  Verbascoside as the internal reference substance, the relative correction factor with other nine components was established. The contents of each component were calculated by external standard method and HPLC-QAMS method, and the test results were compared to verify the accuracy and feasibility of the established HPLC-QAMS method. The cluster analysis, principal component analysis and partial least squares-discriminant analysis of HPLC-QAMS test results were performed by chemometrics methods to establish the comprehensive quality evaluation method of Qirong Runchang oral liquid.

Results  There was a good linear relationship among the 10 quantitative control components in Qirong Runchang oral liquid (r>0.9990). The average recovery was 96.92% -100.11% (RSD<2.0%). There was no significant difference in the content between the two methods (P>0.05). The 12 batches of samples could be clustered into three categories by cluster analysis. The principal component analysis and partial least squares-discriminant analysis show that echinacoside, calycosin-7-O-β-D-glucopyranoside, atracylenolide Ⅲ, tubuloside A and verbascoside were the main markers affecting the difference of samples from different batches of Qirong Runchang oral liquid.

Conclusion  The comprehensive quality evaluation method of HPLC-QAMS quantitative control of multi-components combined with chemometrics is accurate, repeatability and stability, which can be used for the quality control of Qirong Runchang oral liquid.

Full-text
Please download the PDF version to read the full text: download
References

1.任芳, 王海明, 冯宇, 等. 芪蓉润肠口服液治疗化疗后便秘疗效观察[J].北京中医药, 2017, 36(10): 897-899. [Ren F, Wang HM, Feng Y, et al. Clinical observation of Qirong Runchang oral liquid in the treatment of chemotherapy-induced constipation[J]. Beijing Journal of Traditional Chinese Medicine, 2017, 36(10): 897-899.] DOI: 10.16025/j.1674-1307.2017.10.010.

2.张燕玲, 袁兵源, 周志聪, 等. 芪蓉润肠口服液治疗老年慢性便秘的效果探究[J].中国实用医药, 2020, 15(24): 107-109. [Zhang YL, Yuan BY, Zhou ZC, et al. Study on the effect of Qirong Runchang oral liquid in the treatment of chronic constipation in the elderly[J].China Practical Medical, 2020, 15(24): 107-109.] DOI: 10.14163/j.cnki.11-5547/r.2020.24.046.

3.仪松, 陈丽佳, 耿怡, 等. 乳果糖与芪蓉润肠口服液治疗阿片类药物所致便秘的疗效比较[J]. 天津药学 , 2018, 30(6): 26-29. [Yi S, Chen LJ, Geng Y, et al. Comparison of lactulose and Qirong Runchang oral liquid in the treatment of opioid - induced constipation[J].Tianjin Pharmacy, 2018, 30(6): 26-29.] DOI: 10.3969/j.issn.1006-5687.2018.06.009.

4.刘永康, 杨士斌. 芪蓉润肠口服液与乳果糖对肛肠术后患者排便功能的影响[J].中国现代医药杂志, 2019, 21(8): 65-66. [Liu YK, Yang SB. Effect of Qirong Runchang oral liquid and lactulose on defecation function of patients after anorectal surgery[J]. Modern Medicine Journal of China, 2019, 21(8): 65-66.] DOI: 10.3969/j.issn.1672-9463.2019.08.019.

5.国家药品监督管理局药品标准WS3-001(Z-001)-2003(Z)[S]. 2003.

6.闫瑶, 孟新源, 许欢欢, 等. 高效液相色谱法测定芪蓉润肠口服液中松果菊苷与毛蕊花糖苷的含量[J]. 新疆医科大学学报, 2018, 41(7): 886-888,892. [Yan Y, Meng XY, Xu HH, et al. Determination of echinacoside and verbascoside in Qirong Runchang oral liquid by using HPLC[J]. Journal of Xinjiang Medical University, 2018, 41(7): 886-888,892.] DOI: 10.3969.j.issn.1009-5551.2018.07.020.

7.李紫岩,杨敏,王杰,等.以7种有效成分为指标评价内蒙古不同产地黄芪药材品质[J].中国现代中药, 2020, 22(1): 65-73. [Li ZY, Yang M, Wang J, et al. Evaluation of quality of astragali radix in different producing areas of Inner Mongolia with 7 active ingredients as indicators[J]. Modern Chinese Medicine, 2020, 22(1): 65-73.] DOI: 10.13313/j.issn.1673-4890.20190225006.

8.刘蓬蓬, 张凡, 史辑, 等. UPLC-MS/MS法测定不同温度定向炮制黄芪中8种苷类和4种苷元成分的含量[J].中国药房, 2020, 31(3): 287-293. [Liu PP, Zhang F, Shi J, et al. Determination of 8 glycosides and 4 aglycones in directionally processed astragalus membranaceus under different temperatures by UPLC-MS/MS[J].China Pharmacy, 2020, 31(3): 287-293.] DOI: 10.6039/j.issn.1001-0408.2020.03.07.

9.黄诗莹, 陈秋谷, 王佛长, 等. 黄芪-丹参煎液HPLC指纹图谱及多指标定量测定研究[J].中草药, 2019, 50(20): 4950-4956. [Huang SY, Chen QG, Wang FC, et al. Study on HPLC fingerprint and multicomponents determination of Huangqi- Danshen decoction[J]. Chinese Traditional and Herbal Drugs, 2019, 50(20): 4950-4956.] DOI: 10.7501/j.issn.0253-2670.2019.20.016.

10.李捷, 窦志英, 刘丽婷, 等. 不同加工方法对肉苁蓉内在质量和性状特征的影响[J].中药材, 2021, 44(2): 321-327. [Li J, Dou ZY, Liu LT, et al. Study on the effect of different processing methods on intrinsic quality and characters of Cistanches Herba[J]. Journal of Chinese Medicinal Materials, 2021, 44(2): 321-327.] DOI: 10.13863/j.issn1001-4454.2021.02.012.

11.丁艳霞, 王晓琴, 张英, 等. 基于高效液相色谱的肉苁蓉属药材6个主要苯乙醇苷类成分的含量测定[J].时珍国医国药, 2020, 31(4): 813-816. [Ding YX, Wang XQ, Zhang Y, et al. Quantitative assay of six main phenylethanoid glycosides in Cistanche Herba by high performance liquid chromatography[J]. Lishizhen Medicine and Materia Research, 2020, 31(4): 813-816.] DOI: 10.3969/j.issn.1008-0805.2020.04.012.

12.杨国宁, 毕天琛, 张裕民, 等. 一测多评法测定不同肉苁蓉饮片中8个成分的含量[J].中药材, 2020, 43(7): 1677-1682. [Yang GN, Bi TC, Zhang YM, et al. Determination of 8 components in different Cistanche decoction pieces by QAMS method[J]. Journal of Chinese Medicinal Materials, 2020, 43(7): 1677-1682.] DOI: 10.13863/j.issn1001-4454.2020.07.027.

13.王悦, 周巧, 张学兰, 等. HPLC法同时测定地黄及不同炮制品中8种成分的含量[J].中药材, 2021, 44(1): 64-68. [Wang Y, Zhou Q, Zhang XL, et al. Simultaneous determination of eight compounds contents of rehmanniae radix and its different processed products by HPLC[J]. Journal of Chinese Medicinal Materials, 2021, 44(1): 64-68.] DOI: 10.13863/j.issn1001-4454.2021.02.012.

14.喻欢欢, 钟猛, 丁锐, 等. 一测多评法测定玄参中7种有效成分的含量[J].中国中药杂志, 2017, 42(14): 2719-2724. [Yu HH, Zhong M, Ding R, et al. A quantitative method for simultaneous assay of seven active ingredients with one marker in Scrophularia ningpoensis root[J]. China Journal of Chinese Materia Medica, 2017, 42(14): 2719-2724.] DOI: 10.19540/j.cnki.cjcmm.20170419.008.

15.张金莲, 谢日健, 刘明贵, 等. 不同炮制方法对白术中白术内酯Ⅰ,Ⅱ,Ⅲ含量的影响[J].中国实验方剂学杂志, 2016, 22(21): 15-18. [Zhang JL, Xie RJ, Liu MG, et al. Effect of different processing method on contents of atractylenolide Ⅰ,Ⅱ,Ⅲ in atractylodis macrocephalae rhizoma[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2016, 22(21): 15-18.] DOI: 10.13422/j.cnki.syfjx.2016210015.

16.王小平, 杨丽珠, 陈育青, 等. 多波长高效液相法同时测定土炒白术中3种白术内酯含量[J].中国中医药科技, 2019, 26(1): 44-47. [Wang XP, Yang LZ, Chen YQ, et al. Simultaneous determination of three atractylenolides in soil-fried Atractylodes macrocephala by multi-wavelength high performance liquid chromatography[J]. Chinese Journal of Traditional Medical Science and Technology, 2019, 26(1): 44-47.] DOI: CNKI:SUN:TJYY.0.2019-01-015.

17.崔业波, 程炎, 马晓静, 等. 焦白术饮片质量标准的研究[J].中国医药导刊, 2020, 22(10): 703-708. [Cui YB, Cheng Y, Ma XJ, et al. Research on quality standards of deep-fried atractylodes macrocephala[J]. Chinese Journal of Medical Guide, 2020, 22(10): 703-708.] DOI: 10.3969/j.issn.1009-0959.2020.10.008.

Popular papers
Last 6 months